Behavioral risk assessment in HIV Vaccine Trials Network (HVTN) clinical trials: A qualitative study exploring HVTN staff perspectives

Behavioral risk assessment in HIV Vaccine Trials Network (HVTN) clinical trials: A qualitative study exploring HVTN staff perspectives

Highlights • We evaluate the challenges of behavioral risk assessment in HIV vaccine trials. • We explore the impact of the Step Study on behavioral risk assessment measures. • We identify strategies to overcome challenges to behavioral risk assessment. • We identify strategies to improve the qualit...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Vaccine 2013-09, Vol.31 (40), p.4398-4405
Hauptverfasser: Andrasik, Michele Peake, Karuna, Shelly T, Nebergall, Michelle, Koblin, Beryl A, Kublin, Jim G
Format: Artikel
Sprache:eng
Schlagworte:
AIDS Vaccines - therapeutic use
Allergy and Immunology
Applied microbiology
Attitude of Health Personnel
Behavior
Behavioral Risk Factor Surveillance System
Biological and medical sciences
Biomedical interventions
Biomedical research
Clinical trials
Data collection
Epidemiology
experts
Fundamental and applied biological sciences. Psychology
HIV
HIV infections
HIV Infections - drug therapy
HIV Infections - prevention & control
Human immunodeficiency virus
Humans
Interviews
landscapes
Medical research
Meetings
Methods
Microbiology
Miscellaneous
Observational studies
Patient Compliance
Qualitative research
risk
Risk analysis
Risk Assessment
Risk behavior
Risk taking
Social sciences
Studies
Surveys and Questionnaires
Vaccine clinical trials
Vaccines
Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)
Virology
Women
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Highlights • We evaluate the challenges of behavioral risk assessment in HIV vaccine trials. • We explore the impact of the Step Study on behavioral risk assessment measures. • We identify strategies to overcome challenges to behavioral risk assessment. • We identify strategies to improve the quality of behavioral risk analysis data.
ISSN:0264-410X
1873-2518
DOI:10.1016/j.vaccine.2013.07.003